Insider trades

Daniel Patrick O'Day, Chairman of Gilead Sciences GILD, has filed 0 purchases and 27 sales on the open market. Over the past 12 months that comes to a net sale of $44.1M. The latest trade was on 06/10.

Daniel Patrick O'Day

Chairman & CEO
First filing
23/01/26
Trades
100 trades
Buys / sales
0 / 27
12-month net buying
−$44.1M
Last trade
06/10

Trading activity

Transactions

Trade type
GILD
Open-market sale10b5-1 plan06/0106/0215,000 sh3 trades$131.46avg.$1,971,870.5−2.4%
GILD
Open-market sale10b5-1 plan04/2804/2910,000 sh2 trades$129.16avg.$1,291,621−1.6%
Open-market sale10b5-1 plan03/2703/3010,000 sh$136.82$1,368,200−1.5%
GILD
Open-market sale10b5-1 plan02/2703/0210,000 sh3 trades$144.79avg.$1,447,884.66−1.5%
Open-market sale10b5-1 plan02/0502/06115,640 sh$150.00$17,346,000−15.9%
GILD
Open-market sale10b5-1 plan01/2801/2910,000 sh2 trades$139.89avg.$1,398,877.6−1.8%
Open-market sale10b5-1 plan01/2301/26115,640 sh$135.00$15,611,400−16.9%
Open-market sale10b5-1 plan25/12/2925/12/3010,000 sh$124.83$1,248,300−1.7%
GILD
Open-market sale10b5-1 plan25/11/2825/12/0110,000 sh2 trades$126.54avg.$1,265,412.84−1.7%
GILD
Open-market sale10b5-1 plan25/10/2825/10/2910,000 sh2 trades$119.39avg.$1,193,944.16−1.7%
GILD
Open-market sale10b5-1 plan25/09/2925/09/3010,000 sh2 trades$111.66avg.$1,116,562.95−1.7%
Open-market sale10b5-1 plan25/08/2825/08/2910,000 sh$113.63$1,136,300−1.7%
GILD
Open-market sale10b5-1 plan25/07/2825/07/2910,000 sh2 trades$113.94avg.$1,139,377.4−1.6%
GILD
Open-market sale10b5-1 plan25/06/3025/07/0110,000 sh2 trades$110.45avg.$1,104,450−1.6%
GILD
Open-market sale10b5-1 plan25/05/3025/06/0210,000 sh2 trades$110.41avg.$1,104,146.4−1.6%